UK meningitis cases climb to 34

Health authorities in the United Kingdom have confirmed a rise in meningitis cases linked to an outbreak in southeast England, with total infections increasing from 29 to 34.
Officials disclosed that 23 of the cases have been laboratory confirmed, while the remaining are classified as probable infections connected to the outbreak.
The situation has prompted urgent public health measures, particularly at the University of Kent, where a number of cases have been identified.
Large crowds of students gathered on campus to receive meningitis B vaccines, following high demand that left some unable to access doses a day earlier.
Data released by the UK Health Security Agency (UKHSA) shows that more than 5,700 vaccine doses have been administered, while over 11,000 antibiotic treatments have been distributed across Kent, the epicentre of the outbreak.
The disease, Meningitis, is a serious and potentially fatal infection that can lead to sepsis when it affects the membranes surrounding the brain and spinal cord.
So far, two fatalities have been recorded—a university student and a schoolgirl—while several others, mostly young people, remain hospitalised.
Investigations suggested the outbreak may be linked to a popular nightlife venue, Club Chemistry, with authorities urging anyone who visited the club between March 5 and 7 to seek medical attention and preventive treatment.
According to UKHSA, most confirmed infections are linked to meningococcal group B (MenB), a bacterial strain known to cause severe illness.
Bacterial meningitis is generally less common but far more dangerous than viral forms of the disease.
Vaccination against MenB has been part of routine immunisation for infants in the UK since 2015, but health experts warned that older age groups, including students, remain vulnerable.
Public health officials have cautioned that isolated cases could emerge in other parts of the country, particularly as students travel home, although they stress that such clusters are likely to be limited and manageable.
One related case has already been reported in France, where a student connected to the University of Kent is receiving treatment in stable condition.
Early symptoms of meningitis include headache, fever, drowsiness, and neck stiffness—signs that can easily be mistaken for other illnesses, complicating early diagnosis.
As the condition progresses, patients may develop a rash, and the disease can spread through close contact such as kissing or sharing drinks.
Authorities continue to monitor the situation closely while intensifying vaccination and awareness efforts to contain the outbreak



